Skip to content
Search

Latest Stories

NPA board update: David Thomas succeeds Raj Aggarwal OBE

David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.


Ashley Cohen, Sanjeev Panesar, Sukhi Basra, Salim Jetha, Olivier Picard, and Nick Kaye continue their terms without needing to stand for election this time. They still have another two years to run on their terms as board members.

Two board positions remain open. The nomination process is ongoing in Northern Ireland, while in England, five NPA members are contesting the remaining seat, which is open to any member with up to five pharmacies.

The NPA provided Pharmacy Business with the names of the five candidates. They are:
  1. Baba Akomolafe
  2. James Famakin
  3. Simon Harris
  4. Matt Harvey
  5. Mike Hewitson

Hustings for this final board position in England will take place shortly and a ballot for this position will take place later this month, the NPA said.

Recruitment is also currently underway for the new chief executive to succeed Paul Rees.  

Paul Rees MBE stepped down as NPA chief executive in the new year to take on a new role as interim chief executive and registrar of the Nursing and Midwifery Council (NMC).

He joined the NMC on a one-year contract starting January 20, where he is responsible for overseeing the development of a multi-year programme aimed at transforming the NMC’s culture and performance.

New Board to resume work in April 

The current Board will hold its final meetings on 10–11 March, with the newly elected members assuming their roles in April.

NPA chair Nick Kaye welcomed Thomas to the board, which he described as “the dynamic, diverse and innovative national leadership of independent community pharmacy”.

On his new role, David said: “It’s a great privilege and I’ll do my utmost to ensure that NPA members in Wales are well represented and supported throughout my period on the board.”

Raj Aggarwal OBE, a longstanding board member, will step down from the position after more than a decade of service.

Under the NPA’s modified governance cycle, around half of the board positions are up for election every two years.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less